Lilia-Celine (Lily) Lozada
Stock Analyst at J.P. Morgan
(1.58)
# 3,495
Out of 5,032 analysts
17
Total ratings
60%
Success rate
-0.6%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lilia-Celine (Lily) Lozada
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| XRAY DENTSPLY SIRONA | Reiterated: Hold | $12 | $8.56 | +40.19% | 3 | Sep 17, 2026 | |
| NVST Envista Holdings | Upgraded: Buy | $29 → $32 | $23.34 | +37.10% | 4 | Sep 3, 2026 | |
| ATRC AtriCure | Reiterated: Hold | $36 | $56.37 | -36.14% | 5 | Jul 24, 2026 | |
| TMCI Treace Medical Concepts | Downgraded: Sell | $8 → $5 | $4.49 | +11.36% | 5 | Nov 7, 2025 |
DENTSPLY SIRONA
Sep 17, 2026
Reiterated: Hold
Price Target: $12
Current: $8.56
Upside: +40.19%
Envista Holdings
Sep 3, 2026
Upgraded: Buy
Price Target: $29 → $32
Current: $23.34
Upside: +37.10%
AtriCure
Jul 24, 2026
Reiterated: Hold
Price Target: $36
Current: $56.37
Upside: -36.14%
Treace Medical Concepts
Nov 7, 2025
Downgraded: Sell
Price Target: $8 → $5
Current: $4.49
Upside: +11.36%